Valeant Pharmaceuticals International Inc (NYSE:VRX)

210.42
Delayed Data
As of Apr 24
 +1.03 / +0.49%
Today’s Change
106.00
Today|||52-Week Range
211.57
+47.03%
Year-to-Date

Today’s Trading

Previous close209.39
Today’s open210.39
Day’s range208.00 - 211.00
Volume1,515,541
Average volume (3 months)2,856,703
Market cap$71.7B
Dividend yield--
Data as of 4:01pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+26.62%
Earnings growth (next 5 years)+26.30%
Revenue growth (last year)+43.22%
P/E ratio78.7
Price/Sales5.83
Price/Book13.25

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.14-0.29%
LLYEli Lilly and Co-0.82-1.13%
AZNAstraZeneca-1.34-1.83%
SHPGShire-0.26-0.10%
Data as of 4:04pm ET, 04/24/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)$2.33
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers